Renascience Inc. (4889) Other
Market cap
¥18.4B
P/E ratio
-53.3x
Rena Science develops pharmaceuticals, medical devices, and AI-powered software to address critical health challenges including cancer, diabetes, and age-related diseases.
| 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Return on Assets | - | - | - | - | 6.2 | -5.1 | -4.6 | -1.6 | 5.7 |
| Return on equity (%) | - | - | - | ||||||
| Employees | 2 | 1 | 7 | 10 | 7 | 4 | 3 | 4 | 3 |